Metraipolis › archive › dc_3802ae3e8d8a

USP25 aggravates liver cancer development and impairs chemosensitivity by limiting LATS1 activation — Europe PMC PMID:41882191

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41882191
DOI
10.1038/s44319-[numero omesso]-w
License (as archived)
solo-consultazione
Archived
2026-11-03T21:43:50.709Z
SHA-256 of the archived text
5b708c15ff1034980a9d88a0ba063dde951e1a6015df22678838496d9cc50fd6
Stable URL of this page
https://metraipolis.com/documento/dc_3802ae3e8d8a

How to cite

USP25 aggravates liver cancer development and impairs chemosensitivity by limiting LATS1 activation — Europe PMC PMID:41882191 — Europe PMC (en), https://europepmc.org/article/MED/41882191 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3802ae3e8d8a (Metraipolis archive dc_3802ae3e8d8a, sha256 5b708c15ff1034980a9d88a0ba063dde951e1a6015df22678838496d9cc50fd6)
BibTeX
@misc{dc3802ae3e8d8a,
  title = {USP25 aggravates liver cancer development and impairs chemosensitivity by limiting LATS1 activation — Europe PMC PMID:41882191},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41882191},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3802ae3e8d8a; sha256 5b708c15ff1034980a9d88a0ba063dde951e1a6015df22678838496d9cc50fd6},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41882191. Agents can read the archived copy with the MCP tool read_document.